Precise genetic mapping and haplotype analysis of the familial dysautonomia gene on human chromosome 9q31
- PMID: 10090896
- PMCID: PMC1377835
- DOI: 10.1086/302339
Precise genetic mapping and haplotype analysis of the familial dysautonomia gene on human chromosome 9q31
Abstract
Familial dysautonomia (FD) is an autosomal recessive disorder characterized by developmental arrest in the sensory and autonomic nervous systems and by Ashkenazi Jewish ancestry. We previously had mapped the defective gene (DYS) to an 11-cM segment of chromosome 9q31-33, flanked by D9S53 and D9S105. By using 11 new polymorphic loci, we now have narrowed the location of DYS to <0.5 cM between the markers 43B1GAGT and 157A3. Two markers in this interval, 164D1 and D9S1677, show no recombination with the disease. Haplotype analysis confirmed this candidate region and revealed a major haplotype shared by 435 of 441 FD chromosomes, indicating a striking founder effect. Three other haplotypes, found on the remaining 6 FD chromosomes, might represent independent mutations. The frequency of the major FD haplotype in the Ashkenazim (5 in 324 control chromosomes) was consistent with the estimated DYS carrier frequency of 1 in 32, and none of the four haplotypes associated with FD was observed on 492 non-FD chromosomes from obligatory carriers. It is now possible to provide accurate genetic testing both for families with FD and for carriers, on the basis of close flanking markers and the capacity to identify >98% of FD chromosomes by their haplotype.
Similar articles
-
Localization of the gene for familial dysautonomia on chromosome 9 and definition of DNA markers for genetic diagnosis.Nat Genet. 1993 Jun;4(2):160-4. doi: 10.1038/ng0693-160. Nat Genet. 1993. PMID: 8102296
-
Recombinant mapping of the familial hyperinsulinism gene to an 0.8 cM region on chromosome 11p15.1 and demonstration of a founder effect in Ashkenazi Jews.Hum Mol Genet. 1995 May;4(5):879-86. doi: 10.1093/hmg/4.5.879. Hum Mol Genet. 1995. PMID: 7633448
-
Prenatal diagnosis of familial dysautonomia by analysis of linked CA-repeat polymorphisms on chromosome 9q31-q33.Am J Med Genet. 1995 Nov 20;59(3):349-55. doi: 10.1002/ajmg.1320590314. Am J Med Genet. 1995. PMID: 8599360
-
Familial dysautonomia.Clin Auton Res. 2023 Jun;33(3):269-280. doi: 10.1007/s10286-023-00941-1. Epub 2023 May 19. Clin Auton Res. 2023. PMID: 37204536 Review.
-
IKBKAP/ELP1 gene mutations: mechanisms of familial dysautonomia and gene-targeting therapies.Appl Clin Genet. 2017 Dec 15;10:95-103. doi: 10.2147/TACG.S129638. eCollection 2017. Appl Clin Genet. 2017. PMID: 29290691 Free PMC article. Review.
Cited by
-
Afferent baroreflex failure in familial dysautonomia.Neurology. 2010 Nov 23;75(21):1904-11. doi: 10.1212/WNL.0b013e3181feb283. Neurology. 2010. PMID: 21098405 Free PMC article.
-
The molecular basis of familial dysautonomia: overview, new discoveries and implications for directed therapies.Neuromolecular Med. 2008;10(3):148-56. doi: 10.1007/s12017-007-8019-5. Epub 2007 Nov 6. Neuromolecular Med. 2008. PMID: 17985250 Review.
-
Familial Dysautonomia: Mechanisms and Models.Genet Mol Biol. 2016 Oct-Dec;39(4):497-514. doi: 10.1590/1678-4685-GMB-2015-0335. Epub 2016 Aug 4. Genet Mol Biol. 2016. PMID: 27561110 Free PMC article.
-
Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia.Am J Hum Genet. 2001 Mar;68(3):598-605. doi: 10.1086/318810. Epub 2001 Jan 22. Am J Hum Genet. 2001. PMID: 11179008 Free PMC article.
-
Current treatments in familial dysautonomia.Expert Opin Pharmacother. 2014 Dec;15(18):2653-71. doi: 10.1517/14656566.2014.970530. Epub 2014 Oct 17. Expert Opin Pharmacother. 2014. PMID: 25323828 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical